Alum, E. U. (2024). Role of phytochemicals in cardiovascular disease management: Insights into mechanisms, efficacy, and clinical application. Phytomedicine Plus, 5(1), 100695.

Arthur, D. E., & Uzairu, A. (2019). Molecular docking studies on the interaction of NCI anticancer analogues with human phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. Journal of King Saud University – Science, 31(4), 1151–1166.

Azman, M., Sabri, A. H., Anjani, Q. K., Mustaffa, M. F., & Hamid, K. A. (2022). Intestinal absorption study: Challenges and absorption enhancement strategies in improving oral drug delivery. Pharmaceuticals, 15(8), 975.

Bakrim, S., Benkhaira, N., Bourais, I., Benali, T., Lee, L.-H., El Omari, N., Sheikh, R. A., Goh, K. W., Ming, L. C., & Bouyahya, A. (2022). Health benefits and pharmacological properties of stigmasterol. Antioxidants, 11(10), 1912.

Balamuragan, R., Stalin, A., Aravinthan, A., & Kim, J. (2015). Sitosterol a potent hypolipidemic agent: In silico docking analysis. Medicinal Chemistry Research, 24, 124–130.

Balamurugan, R., Duraipandiyan, V., & Ignacimuthu, S. (2011). Antidiabetic activity of γ-sitosterol isolated from Lippia nodiflora L. in streptozotocin induced diabetic rats. European Journal of Pharmacology, 667, 410–418.

Barratt, E., Bingham, R. J., Warner, D. J., Laughton, C. A., Phillips, S. E. V., & Homans, S. W. (2005). Van der Waals interactions dominate ligand–protein association in a protein binding site occluded from solvent water. Journal of the American Chemical Society, 127(33), 11827–11834.

Barrera-Chimal, J., Bonnard, B., & Jaisser, F. (2022). Roles of mineralocorticoid receptors in cardiovascular and cardiorenal diseases. Annual Review of Physiology, 84(1), 585–610.

Batta, A. K., Xu, G., Honda, A., Miyazaki, T., & Salen, G. (2006). Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat. Metabolism, 55(3), 292–299.

Bauersachs, J., & López-Andrés, N. (2021). Mineralocorticoid receptor in cardiovascular diseases – Clinical trials and mechanistic insights. British Journal of Pharmacology, 179(13), 3119–3134.

Beach, M., Davey, T., Subramanian, P., & Such, G. (2023). Self-healing organic coatings – Fundamental chemistry to commercial application. Progress in Organic Coatings, 183, 107759.

Bell, E. W., & Zhang, Y. (2019). DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. Journal of Cheminformatics, 11, 40.

Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022). Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines, 10(9), 2055.

Biocca, S., Iacovelli, F., Matarazzo, S., Vindigni, G., Oteri, F., Desideri, A., & Falconi, M. (2015). Molecular mechanism of statin-mediated LOX-1 inhibition. Cell Cycle, 14(10), 1583–1595.

Boora, P., Puri, R., Rani, S., & Mehta, M. (2023). Effects of Meconopsis aculeata royle extracts on leukocytosis and eosinophilia induced by milk in albino mice: Anti-asthmatic property. Journal of Scientific Research, 15(3), 819–830.

Bulusu, G., & Desiraju, G. R. (2019). Strong and weak hydrogen bonds in protein–ligand recognition. Journal of the Indian Institute of Science, 100(1), 31–41.

Chai, J., Ling, S., Kanthimathi, M. S., & Kuppusamy, U. R. (2010). Gene regulation in β-sitosterol-mediated stimulation of adipogenesis, glucose uptake, and lipid mobilization in rat primary adipocytes. Genes and Nutrition, 6, 181–188.

Chen, J., Huang, L., Qi, X., & Chen, C. (2019). Insulin receptor trafficking: Consequences for insulin sensitivity and diabetes. International Journal of Molecular Science, 20(20), 5007.

Climent, E., Benaiges, D., & Pedro-Botet, J. (2021). Hydrophilic or lipophilic stains? Frontiers in Cardiovascular Medicine, 8, 687585.

Cramer, D. L., Cheng, B., Tian, J., Clements, J. H., Wypych, R. M., & Martin, S. F. (2020). Some thermodynamic effects of varying nonpolar surfaces in protein-ligand interactions. European Journal of Medicinal Chemistry, 208, 112771.

Cruz-Topete, D., Oakley, R. H., & Cidlowski, J. A. (2020). Glucocorticoid signaling and the aging heart. Frontiers in Endocrinology, 11, 347.

Cuenca-Bermejo, L., Almela, P., Navarro-Zaragoza, J., Villalba, E. F., Gonzalez-Cuello, A., Laorden, M., & Herrero, A. (2021). Cardiac changes in Parkinson’s disease: Lessons from clinical and experimental evidence. International Journal of Molecular Sciences, 22(24), 13488.

De Denus, S., & Spinler, S. A. (2002). Early statin therapy for acute coronary syndromes. The Annals of Pharmacotherapy, 36(11), 1749–1758.

Delle Bovi, R. J., Kim, J., Suresh, P., London, E., & Miller, W. T. (2019). Sterol structure dependence of insulin receptor and insulin-like growth factor 1 receptor activation. Biochimica et Biophysica Acta – Biomembranes, 1861(4), 819–826.

Dhorajiwala, T., Halder, S., & Samant, L. (2019). Comparative in silico molecular docking analysis of L-threonine-3-dehydrogenase, a protein target against African trypanosomiasis using selected phytochemicals. Journal of Applied Biotechnology Reports, 6(3), 101–108.

Di Cesare, M., Perel, P., Taylor, S., Kabudula, C., Bixby, H., Gaziano, T. A., McGhie, D. V., Mwangi, J., Pervan, B., Narula, J., Pineiro, D., & Pinto, F. J. (2024). The heart of the world. Global Heart, 19(1), 11.

Di, L., & Obach, R. S. (2015). Addressing the challenges of low clearance in drug research. The AAPS Journal, 17(2), 352–357.

Duong, H., & Bajaj, T. (2025). Lovastatin. StatPearls, Treasure Island.

Endrini, S., Rahmat, A., Ismail, P., & Tafuiq-Yap, Y. H. (2014). Cytotoxic effect of γ-sitosterol from kejibeling (Strobilanthes crispus) and its mechanism of action towards c-myc gene expression and apoptotic pathway. Medical Journal of Indonesia, 23(4), 203–208.

Escribano, O., Beneit, N., Rubio-Longas, C., Lopez-Pastor, A. R., & Gomez-Hernandez, A. (2017). The role of insulin receptor isoforms in diabetes and its metabolic and vascular complications. Journal of Diabetes Research, 2017, 1403206.

Farvid, M. S., Ding, M., Pan, A., Sun, Q., Chiuve, S. E., Steffen, L. M., Willett, W. C., & Hu, F. B. (2014). Dietary linoleic acid and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Circulation, 130(18), 1568–1578.

Ferenczy, G. G., & Kellermayer, M. (2022). Contribution of hydrophobic interactions to protein mechanical stability. Computational and Structural Biotechnology Journal, 20, 1946–1956.

Freire, E. (2009). A thermodynamic approach to the affinity optimization of drug candidates. Chemical Biology and Drug Design, 74(5), 468–472.

Fu, Y., Zhao, J., & Chen, Z. (2018). Insights into the molecular mechanisms of protein-ligand interactions by molecular docking and molecular dynamics simulation: A case of oligopeptide binding protein. Computational and Mathematical Methods in Medicine, 2018, 3502514.

Fyhrquist, F., Metsärinne, K., & Tikkanen, I. (1995). Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. Journal of Human Hypertension, 9(S5), S19–S24.

Garzon-Siatoya, W. T., Carrillo-Martin, I., Chiarella, S. E., & Gonzalez-Estrada, A. (2021). State-of-the-art beta-adrenoreceptor agonists for the treatment of asthma. Expert Opinion on Pharmacotherapy, 23(2), 243–254.

Gelosa, P., Cimino, M., Pignieri, A., Tremoli, E., Guerrini, U., & Sironi, L. (2007). The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation. Vascular Health and Risk Management, 3(5), 567–577.

Georgianos, P. I., & Agarwal, R. (2022). The nonsteroidal mineralocorticoid-receptor-antagonist finerenone in cardiorenal medicine: A state-of-the-art review of the literature. American Journal of Hypertension, 36(3), 135–143.

Grosu, L., Grosu, A. I., Crisan, D., Zlibut, A., & Perju-Dumbrava, L. (2023). Parkinson's disease and cardiovascular involvement: Edifying insights (review). Biomedical Reports, 18(3), 25.

Hamedi, A., Sakhteman, A., & Moheimani, S. M. (2020). An in silico approach towards investigation of possible effects of essential oils constituents on receptors involved in cardiovascular diseases (CVD) and associated risk factors (diabetes mellitus and hyperlipidemia). Cardiovascular and Hematological Agents in Medicinal Chemistry, 19(1), 32–42.

Hundemer, G. L., & Sood, M. M. (2021). Hyperkalemia with RAAS inhibition: Mechanism, clinical significance, and management. Pharmacological Research, 172, 105835.

Jayaraman, S., Devarajan, N., Rajagopal, P., Babu, S., Ganesan, S. K., Veeraraghavan, V. P., Palanisamy, C. P., Cui, B., Periyasamy, V., & Chandrasekar, K. (2021). β-Sitosterol circumvents obesity induced inflammation and insulin resistance by down-regulating IKKβ/NF-κB and JNK signaling pathway in adipocytes of type 2 diabetic rats. Molecules, 26(7), 2101.

Jhund, P. S., Talebi, A., Henderson, A. D., Claggett, B. L., Vaduganathan, M., Desai, A. S., Lam, C. S. P., Pitt, B., Senni, M., Shah, S. J., Voors, A. A., Zannad, F., Solomon, S. D., & McMurray, J. J. V. (2024). Mineralocorticoid receptor antagonists in heart failure: An individual patient level meta-analysis. The Lancet, 404(10458), 1119–1131.

Jimenez, J., & Benitez, M. J. (2024). Gibbs free energy and enthalpy-entropy compensation in protein-ligand interactions. Biophysica, 4(2), 21.

Kadam, P., Yadav, K., Karanje, A., Giram, D., Mukadam, R., & Patil, M. (2023). The food and medicinal benefits of oyster mushroom (Pleurotus ostreatus): A review. International Journal of Pharmaceutical Sciences and Research, 14(2), 883–890.

Keller, F., Maiga, M., Neumayer, H. H., Lode, H., & Distler, A. (1984). Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease. European Journal of Drug Metabolism and Pharmacokinetics, 9(3), 275–282.

Kemp, B. E., Mitchelhill, K. I., Stapleton, D., Michell, B. J., Chen, Z., & Witters, L. A. (2022). Dealing with energy demand: The AMP-activated protein kinase. Trends in Biochemical Sciences, 24(1), 22–25.

Klein, K., & Zanger, U. M. (2013). Pharmacogenomics of cytochrome P450 3A4: Recent progress toward the "missing heritability" problem. Frontiers in Genetics, 4, 12.

Kwiecinski, J. M., & Horswill, A. R. (2021). Staphylococcus aureus bloodstream infections: Pathogenesis and regulatory mechanisms. Current Opinion in Microbiology, 53, 51–60.

Liu, B., Zhang, T., Knight, J. K., & Goodwin, J. E. (2019). The glucocorticoid receptor in cardiovascular health and disease. Cells, 8(10), 1227.

Lutgens, E., & Daemen, M. J. (2004). HMG-coA reductase inhibitors: Lipid-lowering and beyond. Drug Discovery Today Therapeutic Strategies, 1(2), 189–194.

Mahon, C. R., & Lehman, D. C. (2023). Textbook of diagnostic microbiology. 7th ed. Elsevier.

Majewski, M., Ruiz-Carmona, S., & Barril, X. (2019). An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Communications Chemistry, 2, 110.

Malinowski, J. T., & Jean Jr., D. J. S. (2018). Next-generation small molecule therapies for heart failure: 2015 and beyond. Bioorganic and Medicinal Chemistry Letters, 28(9), 1429–1435.

Mcguire, T. F., Xu, X. Q., Corey, S. J., Romero, G. G., & Sebti, S. M. (1994). Lovastatin disrupts early events in insulin signaling: A potential mechanism of lovastatins anti-mitogenic activity. Biochemical and Biophysical Research Communication, 204(1), 399–406.

Messerli, F. H., Bangalore, S., Bavishi, C., & Rimoldi, S. F. (2018). Angiotensin-converting enzyme inhibitors in hypertension: To use or not to use? Journal of the American College of Cardiology, 71(13), 1474–1482.

Mishra, V., Tomar, S., Yadav, P., Vishwakarma, S., & Singh, M. P. (2022). Elemental analysis, phytochemical screening and evaluation of antioxidant, antibacterial and anticancer activity of Pleurotus ostreatus through in vitro and in silico approaches. Metabolites, 12(9), 821.

Montaigne, D., Butruille, L., & Staels, B. (2021). PPAR control of metabolism and cardiovascular functions. Nature Reviews Cardiology, 18(12), 809–823.

Mulder, T. A. M., van Eerden, R. A. G., de With, M., Elens, L., Hesselink, D. A., Matic, M., Bins, S., Mathijssen, R. H. J., & van Schaik, R. H. N. (2021). CYP3A4*22 genotyping in clinical practice: Ready for implementation? Frontiers in Genetics, 12, 711943.

Muscogiuri, G. Sarno, G., Gastaldelli, A., Savastano, S., Ascione, A., Colao, A., & Orio, F. (2014). The good and bad effects of statins on insulin sensitivity and secretion. Endocrine Research, 4, 137–143.

Muslin, A. J. (2008). MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clinical Science, 115(7), 203–218.

Naikwadi, P. H., Mane, D. V., & Phatangre, N. (2023). Active anti-inflammatory potency of γ-sitosterol from Woodfordia floribunda Salisb. The Journal of Plant Science Research, 38(2), 691–700.

Nishiyama, A. (2018). Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease. Hypertension Research, 42(3), 293–300.

Odhar, H. A., Hashim, A. F., & Humad, S. S. (2022). Molecular docking analysis and dynamics simulation of salbutamol with the monoamine oxidase B (MAO-B) enzyme. Bioinformation, 18(3), 304–309.

Onetto, A. J., Sharif, S. (2023). Drug distribution. StatPearls, Treasure Island.

Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One, 5(8), e12029.

Piska, K., Sułkowska-Ziaja, K., & Muszyńska, B. (2017). Edible mushroom Pleurotus ostreatus (oyster mushroom) – its dietary significance and biological activity. Acta Scientiarum Polonorum Hortorum Cultus, 16(1), 151–161.

Rakugi, H., Yamakawa, S., & Sugimoto, K. (2020). Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: Findings from esaxerenone. Hypertension Research, 44(4), 371–385.

Ramírez, D., & Caballero, J. (2018). Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Molecules, 23(5), 1038.

Ray, K. K., & Cannon, C. P. (2005). The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. Journal of the American College of Cardiology, 46(8), 1425–1433.

Righetti, P. G., & Boschetti, E. (2013). Low-abundance protein access by combinatorial peptide libraries. In: Righetti, P. G., & Boschetti, E. (Eds.). Low-abundance proteome discovery. Elsevier. Pp. 79–157.

Roth, C., Neal, B., & Lenhoff, A. (2000). Van der Waals interactions involving proteins. Biophysical Journal, 70(2), 977–987.

Sangeetha, K. N., Sujatha, S., Muthusamy, V. S., Anand, S., Shilpa, K., Kumari, P. J., Sarathkumar, B., Thiyagarajan, G., & Lakshmi, B. S. (2017). Current trends in small molecule discovery targeting key cellular signaling events towards the combined management of diabetes and obesity. Bioinformation, 13(12), 394–399.

Shao, C., Wang, J., Tian, J., & Tang, Y. (2020). Coronary artery disease: From mechanism to clinical practice. In: Wang, M. (Ed.). Coronary artery disease: Therapeutics and drug discovery. Springer, Singapore. Pp. 1–36.

Sica, D. A. (2015). Mineralocorticoid receptor antagonists for treatment of hypertension and heart failure. Methodist DeBakey Cardiovascular Journal, 11(4), 235.

Sim, L., Quezada-Calvillo, R., Sterchi, E. E., Nichols, B. L., & Rose, D. R. (2008). Human intestinal maltase – glucoamylase: Crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. Journal of Molecular Biology, 375(3), 782–792.

Sirikhansaeng, P., Tanee, P., Sudmoon, R., & Chaveerach, A. (2017). Major phytochemical as γ-sitosterol disclosing and toxicity testing in Lagerstroemia species. Evidence-Based Complementary and Alternative Medicine, 2017, 7209851.

Srivastava, S., Sahin, M., & Prock, L. (2019). Translational medicine strategies in drug development for neurodevelopmental disorders. Handbook of Behavioral Neuroscience, 29, 309–331.

Sujatha, S., Anand, S., Sangeetha, K. N., Shilpa, K., Lakshmi, J., Balakrishnan, A., & Lakshmi, B. S. (2010). Biological evaluation of (3β)-stigmast-5-en-3-ol as potent anti-diabetic agent in regulating glucose transport using in vitro model. International Journal of Diabetes Mellitus, 2(2), 101–109.

Tatulian, S. A. (2015). Structural dynamics of insulin receptor and transmembrane signaling. Biochemistry, 54(36), 5523–5532.

Terefe, E. M., & Ghosh, A. (2022). Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of phytochemicals isolated from croton dichogamus against the HIV-1 reverse transcriptase. Bioinformatics and Biology Insights, 16, 11779322221125605.

Tripathi, N., Kumar, S., Singh, R., Singh, C. J., Singh, P., & Varshney, V. (2013). Isolation and identification of gamma-sitosterol by GC-MS from roots of Girardinia heterophylla. Oriental Journal of Chemistry, 29(2), 705–707.

Uzzaman, M., Chowdhury, M. K., & Hossen, M. B. (2019). Thermochemical, molecular docking and ADMET studies of Aspirin metabolites. Frontiers in Drug Chemistry and Clinical Research, 2(3), 1–5.

Vaidyanathan, R., Sreedevi, S. M., Ravichandran, K., Vinod, S. M., Krishnan, Y. H., Babu, L. K., Parthiban, P. S., Basker, L., Perumal, T., Rajaraman, V., Arumugam, G., Rajendran, K., & Mahalingam, V. (2023). Molecular docking approach on the binding stability of derivatives of phenolic acids (DPAs) with human serum albumin (HSA): Hydrogen-bonding versus hydrophobic interactions or combined influences? JCIS Open, 12, 100096.

Vijay, U., Gupta, S., Mathur, P., Suravajhala, P., & Bhatnagar, P. (2018). Microbial mutagenicity assay: AMES Test. Bio-Protocol, 8(6), 1–15.

Waktola, G., & Temesgen, T. (2020). Pharmacological activities of oyster mushroom (Pleurotus ostreatus). Novel Research in Microbiology Journal, 4(2), 688–695.

Wanat, K. (2020). Biological barriers, and the influence of protein binding on the passage of drugs across them. Molecular Biology Reports, 47, 3221–3231.

Wang, C. C. L., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016). Clinical update: Cardiovascular disease in diabetes mellitus. Circulation, 133(24), 2459–2502.

Wang, J., Liang, J., Chen, L., Zhang, W., Kong, L., Peng, C., Su, C., Tang, Y., Deng, Z., & Wang, Z. (2021). Structural basis for the biosynthesis of lovastatin. Nature Communications, 12, 867.

Wangchuk, P. (2018). Therapeutic applications of natural products in herbal medicines, biodiscovery programs, and biomedicine. Journal of Biologically Active Products from Nature, 8(1), 1–20.

Wasim, R., Ansari, T. M., Ahsan, F., Siddiqui, M. H., Singh, A., Shariq, M., & Parveen, S. (2022). Pleiotropic benefits of statins in cardiovascular diseases. Drug Research, 72(9), 477–486.

Wright, K. M., DiNapoli, S. R., Miller, M. S., Aitana Azurmendi, P., Zhao, X., Yu, Z., Chakrabarti, M., Shi, W., Douglass, J., Hwang, M. S., Han-Chung Hsiue, E., Mog, B. J., Pearlman, A. H., Paul, S., Konig, M. F., Pardoll, D. M., Bettegowda, C., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Zhou, S., & Gabelli, S. B. (2023). Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen. Nature Communication, 14, 5063.

Wu, M., Dai, D., & Yan, H. (2012). PRL‐dock: Protein-ligand docking based on hydrogen bond matching and probabilistic relaxation labeling. Proteins Structure Function and Bioinformatics, 80(9), 2137–2153.

Wu, N., Zhang, R., Peng, X., Fang, L., Chen, K., & Jestila, J. S. (2024). Elucidation of protein–ligand interactions by multiple trajectory analysis methods. Physical Chemistry Chemical Physics, 26, 6903.

Xie, L., Zhu, G., Shang, J., Chen, X., Zhang, C., Ji, X., Zhang, Q., & Wei, Y. (2021). An overview on the biological activity and anti-cancer mechanism of lovastatin. Cellular Signalling, 87, 110122.

Xu, X. Q., McGuire, T. F., Blaskovich, M. A., Sebti, S. M., & Romero, G. (1996). Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts. Archives of Biochemistry and Biophysics, 326(2), 233–237.

Yang, X., Zhao, T., Feng, L., Shi, Y., Jiang, J., Liang, S., Sun, B., Xu, Q., Duan, J., & Sun, Z. (2019). PM2.5-induced ADRB2 hypermethylation contributed to cardiac dysfunction through cardiomyocytes apoptosis via PI3K/Akt pathway. Environment International, 127, 601–614.

Yazdi, S., Stein, M., Elinder, F., Andersson, M., & Lindahl, E. (2016). The molecular basis of polyunsaturated fatty acid interactions with the shaker voltage-gated potassium channel. Computational Biology, 12(1), e1004704.

Yoshida, T., Oki, H., Doi, M., Fukuda, S., Yuzuriha, T., Tabata, R., Ishimoto, K., Kawahara, K., Ohkubo, T., Miyachi, H., Doi, T., & Tachibana, K. (2020). Structural basis for PPARα activation by 1H-pyrazolo-[3,4-b]pyridine derivatives. Scientific Reports, 10(1), 7623.

Zhang, H., Unal, H., Desnoyer, R., Han, G. W., Patel, N., Katritch, V., Karnik, S. S., Cherezov, V., & Stevens, R. C. (2015). Structural basis for ligand recognition and functional selectivity at angiotensin receptor. Journal of Biological Chemistry, 290(49), 29127–29139.

Zhao, D. (2021). Epidemiological features of cardiovascular disease in Asia. JACC: Asia, 1(1) 1–13.

Zhao, Q., Liu, X., Cui, L., & Ma, C. (2024). Extraction and bioactivities of the chemical composition from Pleurotus ostreatus: A review. Journal of Future Foods, 4(2), 111–118.

Zhou, S., Yung Chan, S., Cher Goh, B., Chan, E., Duan, W., Huang, M., & McLeod, H. L. (2005). Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clinical Pharmacokinetics, 44(3), 279–304.